Knotless Tissue Control Devices Market Outlook:
Knotless Tissue Control Devices Market size was over USD 512.4 million in 2025 and is projected to reach USD 695.34 million by 2035, growing at around 3.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of knotless tissue control devices is evaluated at USD 526.7 million.
The primary growth factor for the knotless tissue control devices market to expand is the high number of surgeries performed worldwide. As per recent estimates done in 2020, it was revealed that around 300 million major surgeries are performed each year globally; out of which 50 million were done in the United States and 20 million in Europe. The increasing number of surgeries is attributed to rising accidents and chronic disorders. An increasing number of accidents count across the world is growing day by day with huge traffic and the negligence of people. And most of these accidents cause minor or major injuries that need surgery. Sutures are the only way to prevent the loss of blood and enhance the healing process during such situations.
Knotless tissue control devices are generally absorbable and antibacterial that are developed to facilitate soft tissue approximation. These devices provide enhanced performance characteristics and wound-holding security with added features that offer increased efficiency and control. The great advantages of knotless tissue control devices such as distribution of tension along the wound, simplified knot tying, and reduced knot-related complications, are expected to boost the demand for knotless tissue control devices in the healthcare industry. Thus, the high number of surgeons in the healthcare sector is projected to increase the adoption rate of knotless tissue control devices. As of 2022, in the United States, there were about 54,800 surgical physicians.
